EpiCARE is the European Reference Network for all rare and complex epilepsies. The ERNs aim to improve care for rare diseases, reduce inequalities in access to the best diagnostic, treatment practices and investigational tools.
The ERN is composed by 61 medical teams of experts, accredited by their respective national authorities and the European Commission. It is present in 24/27 EU countries and in Norway. Supporting medical teams are present in Bulgaria, Greece, Ireland, Switzerland and in the UK.
In October 2023, the administrative coordination of EpiCARE was entrusted to the Hospital Sant Joan de Déu in Barcelona, under the leadership and coordination of Professor Dr. Alexis Arzimanoglou.
The workshop “Challenging Focal Cortical Dysplasias & Autoimmune Diseases with Epilepsy,” endorsed by ERN EpiCARE, was a success with 156 participants. It featured excellent multidisciplinary sessions adressing topics such as treatment approaches for autoimmune diseases with epileptic seizures, the complex challenges of Focal Cortical Dysplasias (FCDs), Advanced Therapeutic Medicinal Products, and more.
Taking advantage of the workshop’s location in Rome, part of the EpiCARE management team dedicated Sunday morning, 15th December, to sharing their recent work and making key decisions for the future of our ERN. On Monday 16th, the EpiCARE Executive Committee meeting took place. A big thank you to everyone for your valuable contributions.
We’re excited to announce the EPIPED Course 2025, taking place from April 23 to 26 in Girona, Spain! This course marks the second year of the current 3-year EPIPED cycle (2024-2026), a unique, international training designed to bridge geographical and knowledge gaps in epilepsy care.
The EPIPED-Treatment cycle (2024-2026) aims to regularly update neurologists and child neurologists on the best practices in epilepsy treatment.
Save the date!
EpiCARE has launched a series of educational webinars presented by our experts. These webinars on rare and complex epilepsies are free to join from anywhere in the world, however pre-registration is required.
The next webinar you can’t miss:
🧠Join us for an insightful webinar: “Building a Successful International Patient Network in Preparation for Future Scenarios”.
Speakers: ePAG (European Patient Advocacy Group)
🔎An excellent opportunity to expand your knowledge!
🗓️Date: 19th December
🕒Time: 17:00 CET
Registration Link: https://lnkd.in/dbK9r8jW
The Genetic Research workgroup is sharing opportunities of collaborative calls for European series of patients carrying variants in already known genes, to facilitate this type of studies by connecting several centers across Europe involved in the study of genetic epilepsies.
Have a look at the calls for collaborative genetic research here, and contact Sébile Tchaicha, Research project manager, if you have any question !
Supporting research on rare and complex epilepsies in one of EpiCARE’s priorities.
To that effect, the Research Council is sharing some open funding calls opportunities on this webpage.
Do not hesitate to have a look at the calls, and contact Sébile Tchaicha, Research project manager, if you have any question !
The European Reference Networks (ERNs) were launched in 2017. They involve more than 900 highly specialised health care teams, located in more than 300 hospitals in 24 European countries and in Norway. The main mission of the ERNs is to help patients with rare or low-prevalence complex diseases, and to shape healthcare systems and national networks.
A disease is defined as rare when it affects fewer than one in 2 000 people, is serious, chronic and often life-threatening. Between 5 000 and 8 000 of rare diseases affect daily life of around 30 million people in the EU.
The ERN EpiCARE brings together highly specialized health centres (38 full members and 12 affiliated partners) in 26 European countries with expertise in rare and complex epilepsies.
If you are a healthcare professional and would like to refer a patient to us, or if you are a patient yourself, or a family member of a patient, please get in touch via our contact page.
The rare disease community comes together in calling on the EU institutions and our national governments to stand by the European Reference Networks, and to uphold their commitment to enable long-lasting impact in people’s lives and, fundamentally, give all people living with a rare or complex condition in Europe the same opportunities to access timely and adequate specialised healthcare. Read the open letter from the rare disease community here
Accessibility
To improve accessibility of detailed diagnostics to individuals of all ages with rare and complex epilepsies across Europe, including clinical evaluation and investigation.
Developing treatment
To develop treatment protocols and monitor standardised outcomes of rare and complex epilepsies.
Awareness
To improve awareness and accessibility to protocols for physicians and individuals with rare and complex epilepsies across Europe for treatment.
Education
To enhance educational activities and training opportunities across Europe by interchange across the network.
Collaborative research
To enhance opportunities for registries, and collaborative research for the benefit of individuals with rare and complex epilepsies across Europe.
The ZOOM link is always the same for all meetings and attached below for your information. Please feel free to share and invite your colleagues !
On February 6th and 7th, 2025, the International Symposium: Neurodevelopmental Syndromes and Movement Disorders, endorsed by ERN EpiCARE, will be held in Barcelona (Spain). The aim of the event is to continue collaborative activities between professionals interested in neurodevelopmental syndromes and movement disorders. Sign up, and do not miss the chance to showcase your work at the International Symposium. Registration (Deadline December 16th) / Abstract submission (Deadline December 5th)
The ZOOM link is always the same for all meetings and attached below for your information. Please feel free to share and invite your colleagues !
Explore the preliminary program for the 3rd Conference on Artificial Intelligence in Epilepsy and Neurological Disorders (AI Epilepsy 2025).
The ZOOM link is always the same for all meetings and attached below for your information. Please feel free to share and invite your colleagues !
The third International congress on Structural Epilepsy & Symptomatic Seizures will be held in Wallenberg Centre, Gothenburg.
In 2019 and 2023, the first two editions of the congress Seizures and Stroke attracted over 130 participants each, from over ten countries to Gothenburg. Our meeting now returns – with a widened scope to all symptomatic and structural epilepsies. A three-day program of cutting-edge research and clinical presentations are combined with a teaching course for scientists and clinicians starting out in the field, and there are ample poster- and platform-presentation opportunities.
The ZOOM link is always the same for all meetings and attached below for your information. Please feel free to share and invite your colleagues !
We’re excited to announce the EPIPED Course 2025, taking place from April 23 to 26 in Girona, Spain! This course marks the second year of the current 3-year EPIPED cycle (2024-2026), a unique, international training designed to bridge geographical and knowledge gaps in epilepsy care.
Save the date and join the EPIPED Course 2025 in Girona, Spain!
The ZOOM link is always the same for all meetings and attached below for your information. Please feel free to share and invite your colleagues !
The Neurology, Epilepsy and Movement Disorders Unit of Bambino Gesù Children’s Hospital – IRCCS, and the Paediatric Neurorehabilitation Department of San Raffaele IRCCS Rome, Italy with the endorsement of ILAE-Europe, EpiCARE, and Lega Italiana contro l’Epilessia (LICE), present the educational initiative “Drug Resistant Epilepsies – 12th International Residential Course” that will take place in Tagliacozzo, Italy.
Menu
Funding
The ERN EpiCARE was created in 2017 and is co-funded by the European Union.
EpiCARE © 2021 all rights reserved | Privacy Policy | Webdesign : Marc Chaperon
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-advertisement | 1 year | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertisement". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Cookie | Duration | Description |
---|---|---|
YSC | session | This cookies is set by Youtube and is used to track the views of embedded videos. |
Cookie | Duration | Description |
---|---|---|
_ga | 2 years | This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors. |
Cookie | Duration | Description |
---|---|---|
IDE | 1 year 24 days | Used by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile. |
NID | 6 months | This cookie is used to a profile based on user's interest and display personalized ads to the users. |
test_cookie | 15 minutes | This cookie is set by doubleclick.net. The purpose of the cookie is to determine if the user's browser supports cookies. |
VISITOR_INFO1_LIVE | 5 months 27 days | This cookie is set by Youtube. Used to track the information of the embedded YouTube videos on a website. |
Cookie | Duration | Description |
---|---|---|
_ga_K3WGJ1B9KB | 2 years | No description |
CONSENT | 16 years 7 months 7 days 16 hours 17 minutes | No description |